NASDAQ: AUTL - Autolus Therapeutics plc

Rentabilität für sechs Monate: -54.4%
Dividendenrendite: 0.00%
Sektor: Healthcare

Nachricht
Blackstone to invest up to $250 million in Autolus Therapeutics of U.K.

18 november 17:59 Blackstone to invest up to $250 million in Autolus Therapeutics of U.K.